These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 546671)

  • 21. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent)].
    Rodríguez-Miñón JL; Herrera Pombo JL; Marrón JA
    Rev Clin Esp; 1971 Dec; 123(5):439-42. PubMed ID: 5160567
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypoglycaemic and related activities of a new pyrazolopyridine derivative (SQ 65,993).
    Polacek I; Schulze E; Burg H; Ouart J
    Arzneimittelforschung; 1974 Sep; 24(9):1242-7. PubMed ID: 4479785
    [No Abstract]   [Full Text] [Related]  

  • 24. Binding of sulfonylurea derivatives to bovine serum albumin: part II. The relationship of binding to albumin, chemical structure, and hypoglycemic activity of sulfonamide derivatives of 2-pyrazoline-1-carboxamide.
    Wójcikowski C; Brzozowski Z; Chorosiński A
    Pol J Pharmacol Pharm; 1977; 29(5):477-83. PubMed ID: 593965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute, subchronic and chronic toxicity of the new sulfonylurea glimepiride in rats.
    Donaubauer HH; Mayer D
    Arzneimittelforschung; 1993 May; 43(5):547-9. PubMed ID: 8328999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the use of oral antidiabetic drugs].
    Aarseth S
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1595-601. PubMed ID: 4588815
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on oral hypoglycemia agents -- blood levels and hypoglycemic effects of sulfonylurea compounds--.
    Fukuchi H; Tsukiai S; Kumagai M; Kitaura T
    Hiroshima J Med Sci; 1977 Dec; 26(4):269-76. PubMed ID: 615173
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
    Calvet JM; Matarrodona M; Bordas R
    Rev Iber Endocrinol; 1974; 21(124):347-62. PubMed ID: 4453782
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacokinetics and metabolite spectrum of glisoxepide in humans].
    Speck U; Mützel W; Kolb KH; Acksteiner B; Schulze PE
    Arzneimittelforschung; 1974 Mar; 24(0):404-9. PubMed ID: 4408089
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of glipizide in the rat and dog and its tissue distribution in the mouse.
    Goldaniga GC; Maraone C; Pianezzola E; Valzelli G; Ambrogi V
    Arzneimittelforschung; 1973 Feb; 23(2):242-7. PubMed ID: 4739837
    [No Abstract]   [Full Text] [Related]  

  • 33. Long term treatment of diabetes mellitus with glibornuride. A new hypoglycemic agent.
    Nava M; Quibrera R; Pérez Arocha N
    Rev Invest Clin; 1973; 25(2):169-74. PubMed ID: 4198609
    [No Abstract]   [Full Text] [Related]  

  • 34. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
    Domingo Gutiérrez AJ; Fernández-Cruz A
    Rev Iber Endocrinol; 1973; 20(117):289-303. PubMed ID: 4581992
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-diabetic activity and pharmacological actions of a new series of sulphonylurea derivatives.
    Gandhi TP; Jindal MN
    Arzneimittelforschung; 1971 Jul; 21(7):961-7. PubMed ID: 5109510
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral hypoglycemic agents as an alternative therapy for gestational diabetes.
    Hod M; Shafrir E
    Isr J Med Sci; 1995 Oct; 31(10):640-3. PubMed ID: 7591693
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 40. [Liquid chromatography frontal analysis of the protein binding of glimepiride].
    Zhou DW; Wang HF; Li FM
    Yao Xue Xue Bao; 2005 Jan; 40(1):39-42. PubMed ID: 15881325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.